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INTRODUCTION
With one in four adults classified as obese
in the UK,1 bariatric surgery is becoming
an increasingly common weight loss inter-
vention. The number of procedures has
increased from fewer than 1000 proce-
dures performed in 2000 to almost 10 000
in 2010.1 Compared to diet, exercise and
pharmacotherapy, bariatric surgery offers
sustained, long-term weight loss2 and
improvement in obesity-related conditions.
Following surgery, published data suggest
that patients can expect up to a 72%
chance of remission of type 2 diabetes,3
46% resolution of hypertension4 and 75%
improvement in sleep apnoea.5 Weight loss
through bariatric surgery has also been
shown to improve menstrual cycle disorders
and theoretically to improve fertility.6 7
The National Institute for Health and
Care Excellence (NICE) guideline on man-
agement of adult obesity recommends bar-
iatric surgery when other weight loss
interventions have failed.8 National Health
Service criteria for surgery are determined
by a body mass index (BMI) (in kg/m2),
greater than 40, or 35 with significant
disease that could be improved with
weight loss, such as type 2 diabetes or
hypertension. For severely obese patients
with a BMI >50, bariatric surgery may be
considered as a first-line option.8
The UK National Bariatric Surgery
Registry (NBRS) shows that 80% of baria-
tric procedures were performed in women,
with the majority being in the reproductive
age group.1 Compared to women with a
normal BMI, obese women may be up to
three times more likely to experience infer-
tility.7 Generally, women who undergo bar-
iatric surgical procedures experience
improved fertility and maternal outcomes
compared to obese cohorts.6 7 There is a
paucity of literature investigating the
effects of the different bariatric procedures
on contraceptive efficacy, and whether spe-
cific methods should be recommended.
Current recommendations advise against
pregnancy following bariatric surgery for
at least 1 year afterwards,7 9 as the first
2 years following surgery are the period of
most rapid weight loss.2 In addition, the
surgically altered digestive physiology
means that patients have to adjust to new
eating habits and there is potential for
nutrient deficiencies to occur;10 this risk is
increased in patients who undergo malab-
sorptive procedures. The effects of this on
maternal and fetal outcomes have not been
accurately determined. If present rates of
obesity and bariatric surgery continue to
rise, an emerging ‘subgroup’ of women
will require more specialist contraceptive
advice with reproductive health decisions
dependent on the procedure performed,
weight loss experienced and possible
effects on future pregnancies.
BARIATRIC SURGICAL PROCEDURES
Bariatric procedures exhibit their effect on
weight loss and comorbidity improvement
through either a restrictive or a malabsorp-
tion mechanism, or a combination of both.
The most common procedure performed
in the UK is the gastric bypass (55%),1
with gastric sleeve and gastric banding per-
formed less frequently. Most procedures
are performed laparoscopically.
Gastric bypass surgery creates a small
pouch that is separated from the rest of the
stomach (Figure 1). The small intestine is
divided in the middle of the jejunum into
two limbs. The lower limb is attached via
an anastomosis to the gastric pouch and
the upper limb is attached further down
the jejunum, bypassing the stomach, duo-
denum and proximal jejunum. The
stomach pouch is only able to hold a small
amount of food (restrictive); malabsorp-
tion occurs as a result of bypassing the
proximal small bowel. The malabsorptive
effect of gastric bypass requires lifelong
supplementation to prevent nutrient defi-
ciencies.11 Levels of fasting glucose,
insulin, ghrelin (a hormone primarily
responsible for appetite stimulation) and
the gut hormone peptide-YY (an appetite
regulant) are significantly altered following
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bariatric surgery and depend on the type of procedure
performed.12 13 The gastric sleeve is a restrictive proced-
ure that involves removing 80% of the stomach, leaving
a sleeve-shaped organ (Figure 2). There is a theoretical
impact on appetite suppression through reduced pro-
duction of ghrelin, but its metabolic mechanisms are
still not fully understood.14 It is proposed that the effect
of the gastric sleeve on the absorption of oral hormones
cannot be accurately determined at the present time,
and this is an identified area for future research. Gastric
banding involves placing an inflatable band around the
upper portion of the stomach, which creates a small
pouch above the site of the band, allowing for the size
of the stomach opening to be adjusted by filling the
band with a saline solution through a subdermal port.
Gastric banding is reversible, and wholly restrictive with
no malabsorptive component. The number of gastric
banding procedures performed in the UK is declining
due in part to high rates of removal and revision surgery
attributed to patient intolerance, slippage, reflux and
infection.15
REPRODUCTIVE HEALTH AND THE
BARIATRIC PATIENT
Fertility is negatively affected by obesity,16 but the
rapid weight loss imposed by bariatric surgery means
women will experience improved fertility,17 and be at
risk of an unplanned pregnancy. There is no universal
consensus on the timeframe, but the current advice to
avoid pregnancy for at least 1 year, and possibly up to
2 years after surgery,7 9 is intended to reduce any the-
oretical risks to maternal and fetal health as a result of
nutrient deficiencies and rapid weight loss.
Adverse maternal events may be lower in bariatric
surgical patients compared with their obese counter-
parts. A retrospective study comparing 346 pregnant
women who delivered before bariatric surgery with
354 women who delivered after bariatric surgery
found a lower incidence of gestational diabetes (27%
vs 8%).18 A systematic review that included three
matched case-controlled studies by Maggard et al.,7
comparing women who had undergone bariatric
surgery with obese controls, reported a reduced risk
of developing pregnancy-induced hypertension and
pre-eclampsia, along with lower rates of gestational
diabetes. In addition, some studies suggest fewer
neonatal complications such as premature delivery,
macrosomia and low birth weight following bariatric
surgery compared to obese controls.7 9
Thus the choice of contraceptive method in bariatric
patients requires careful consideration to ensure that it
is effective, acceptable to the woman, and that preg-
nancy is avoided.
ABSORPTION OF ORAL CONTRACEPTIVES
FOLLOWING BARIATRIC SURGERY
Adaptation to post-surgical life includes changes to
eating habits that may result in vomiting and diar-
rhoea, known causes of breakthrough bleeding, and
reduced efficacy in women taking all types of oral
contraceptives. Vomiting and diarrhoea may occur
with all procedures, and are generally a result of poor
food choices.19 Other causes of vomiting include food
becoming stuck (banding and sleeve) and anastomotic
stenosis, narrowing of the new connection between
the stomach and lower intestine (gastric bypass).
Frequent or prolonged vomiting should always be
investigated.
The pharmacokinetics of oral contraception is affected
by the type of procedure performed. Oral estrogen is
mostly absorbed in the upper gastrointestinal tract,
which is reshaped as a result of bariatric surgery, particu-
larly with gastric bypass as this altered digestive physi-
ology results in malabsorption. The United States
Medical Eligibility Criteria for Contraceptive Use advises
against oral contraceptives in bariatric patients.20
A ‘before and after’ comparison study of the pharmaco-
kinetics of an ethinylestradiol/levonorgestrel contracep-
tive pill 1 month before and 4 months post-gastric
bypass is currently recruiting surgery-seeking females
aged between 18 and 40 years. The primary outcome
measure is twice-weekly serum hormone levels before
and after surgery; the secondary outcome measures
include twice-weekly endometrial thickness measured by
transvaginal ultrasound for the duration of the study.21
Figure 2 Diagrammatic representation of a sleeve gastrectomy
procedure. Image reproduced with the kind permission of
Dendrite Clinical Systems Ltd.
Figure 1 Diagrammatic representation of a Roux-en-Y gastric
bypass procedure. Image reproduced with the kind permission
of Dendrite Clinical Systems Ltd.
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Currently it is thought that the efficacy of
progestogen-only pills and emergency contraception
pills following malabsorptive procedures may be
reduced and are not recommended.20
No evidence was found to suggest a reduction in
the effectiveness of oral hormones following restrict-
ive procedures.20
NON-ORAL CONTRACEPTIVE USE FOLLOWING
BARIATRIC SURGERY
Patients experience significant weight loss after
surgery, resulting in loose skin, which may affect
contraceptive choices (e.g. there is anecdotal evidence
to suggest difficulties in finding a suitable site for
applying transdermal patches and making insertion of
subdermal implants technically more difficult).
A study of three case reports of obese women (pre-
operative BMI range 51.8–64.7 kg/m2) with etonoges-
trel implants inserted prior to gastric bypass showed
that levels of etonogestrel decreased with weight loss,
but these levels remained sufficiently high to provide
contraceptive efficacy.22
It is thought that the association of weight gain with
injectable methods23 may be unacceptable to bariatric
patients. In addition, the existing potential for bone
mineral density loss with injectable methods23 that
may also occur with bariatric procedures17 is still
under investigation, so this method should be
regarded with caution at present.
Obese women may find vaginal rings, female
condoms, diaphragms and cervical caps difficult to
insert and intrauterine contraceptive threads difficult
to check. Guidance for diaphragm users recommends
visiting a health care professional to check the correct
sizing of this barrier method following a weight
change of 3 kg,23 making this an impractical choice
for bariatric patients.
The psychosocial impact of bariatric surgery is
known to affect interpersonal relationships;24 irrevers-
ible methods of contraception such as male and
female sterilisation or non-surgical blockage of the
Fallopian tubes (Essure®), leading to permanent
lifestyle changes, should be carefully considered fol-
lowing bariatric surgery to avoid later regret.
SUGGESTED CONTRACEPTIVE METHODS FOR
BARIATRIC PATIENTS
Based on current UK and USA contraceptive guide-
lines20 23 for obese women, and accounting for the
theoretical risk for bariatric procedures to reduce oral
hormone absorption, intrauterine devices (IUDs)
(either hormonal or copper) should be offered as a
first-line contraceptive method for bariatric patients.
IUDs offer long-term reversible contraception that is
not affected by surgically imposed weight loss or mal-
absorption, but the device threads may be difficult to
check until significant weight loss is achieved. Current
UK contraception recommendations for obese women
do not assess the impact of bariatric procedures.23
Table 1 is a proposed guide to contraception recom-
mendations for obese women, based on the format of
the UK Medical Eligibility Criteria for Contraceptive
Use,23 and assumes a postoperative BMI of at least
35 kg/m2, based on NICE minimum weight eligibility
criteria for bariatric surgery.
Male condoms are also an option; but as a patient’s
weight decreases, the range of contraceptive options
increases. The risk of adverse events associated with
specific contraceptive methods, obesity, pregnancy and
surgical procedure must be balanced against the needs
of the individual bariatric patient.
CONCLUSIONS
Obese women undergoing bariatric surgery are an
emerging contraceptive-seeking cohort whose needs
are different to those of obese women. Rapid weight
loss and nutritional considerations mean that preg-
nancy should be avoided for at least 1 year following
surgery. Patients undergoing procedures resulting in
malabsorption should not be offered oral hormonal
contraception until the pharmacokinetic changes asso-
ciated with this form of surgery are more clearly
understood. Future research should focus on
Table 1 Proposed contraception for patients following bariatric surgery
Bariatric
procedure COCs POPs
DMPA or
NET-EN
Progestogen-only
implant Cu-IUD LNG-IUS
Combined hormonal
patch, vaginal ring
Gastric bypass 3 3 2 2 1 1 3
Gastric sleeve 2 2 2 2 1 1 2
Gastric banding 2 2 2 2 1 1 2
Definition of categories is based on UK Medical Eligibility Criteria for Contraceptive Use (UKMEC)23 as follows:
1 A condition for which there is no restriction for the use of the contraceptive method.
2 A condition where the advantages of using the method generally outweigh the theoretical or proven risks.
3 A condition where the theoretical or proven risks usually outweigh the advantages of using the method. The provision of a method requires expert
clinical judgement and/or referral to a specialist contraceptive provider, since use of the method is not usually recommended unless other more
appropriate methods are not available or not acceptable.
4 A condition which represents an unacceptable health risk if the contraceptive method is used.
COCs, combined oral contraceptives; Cu-IUD, copper-containing intrauterine device; DMPA; depot medroxyprogesterone acetate; LNG-IUS, levonorgestrel-
releasing intrauterine system; NET-EN, norethisterone enantate; POPs, progestogen-only pills.
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contraceptive outcomes in this cohort and currently
performed procedures.
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Editor’s note Readers may also be interested in a very recent
(August 2014) BMJ State of the Art Review entitled ‘Bariatric
surgery for obesity and metabolic conditions in adults’
(Arterburn DE, Courcoulas AP, BMJ 2014;349:g3961). This
excellent review summarises recent evidence relating to the
safety, efficacy and metabolic outcomes of bariatric surgery to
guide clinical decision making, and complements the specific
issues discussed by Graham et al. in this commentary.
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